Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$870M |
| 2 |
Amazon
AMZN
|
+$319M |
| 3 |
Automatic Data Processing
ADP
|
+$216M |
| 4 |
Evergy
EVRG
|
+$214M |
| 5 |
Chevron
CVX
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$296M |
| 2 |
Mondelez International
MDLZ
|
+$235M |
| 3 |
Abbott
ABT
|
+$229M |
| 4 |
Lam Research
LRCX
|
+$189M |
| 5 |
American International
AIG
|
+$170M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.97% |
| 2 | Technology | 12.66% |
| 3 | Healthcare | 12.25% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Spyre Therapeutics
SYRE
$8.4B
| $5.04M | 0.01% |
19,059
+16,091
| +542% | +$3.96M |
|
|
CPRX
1802
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.02M | 0.01% |
1,610,176
+227,918
| +16% | +$691K |
|
|
TBRGU
1803
DELISTED
Thunder Bridge Acquisition, Ltd. Unit
TBRGU
| $5.02M | 0.01% |
+500,000
| New | +$5.02M |
|
1804
Organogenesis Holdings
ORGO
$223M
| $5.01M | 0.01% |
+500,000
| New | +$5.01M |
|
1805
Resources Connection
RGP
$144M
| $5.01M | 0.01% |
296,765
+268,229
| +940% | +$4.39M |
|
1806
Kforce
KFRC
$1.02B
| $5.01M | 0.01% |
146,190
-91,573
| -39% | -$2.89M |
|
|
PDCE
1807
DELISTED
PDC Energy, Inc.
PDCE
| $5.01M | 0.01% |
82,836
-98,932
| -54% | -$5.7M |
|
|
PARA
1808
CALL
DELISTED
Paramount Global Class B
PARA
| $5M | 0.01% |
+89,000
| New | +$4.65M |
|
1809
CRA International
CRAI
$1.07B
| $4.99M | 0.01% |
97,988
-35,029
| -26% | -$1.93M |
|
1810
Clean Energy Fuels
CLNE
$353M
| $4.97M | 0.01% |
1,347,902
+65,514
| +5% | +$154K |
|
|
NGHC
1811
DELISTED
National General Holdings Corp
NGHC
| $4.97M | 0.01% |
+188,705
| New | +$4.94M |
|
|
HUYA
1812
Huya Inc
HUYA
$491M
| $4.96M | 0.01% |
+150,900
| New | +$4.53M |
|
1813
Mercantile Bank Corp
MBWM
$1.03B
| $4.96M | 0.01% |
134,184
+5,122
| +4% | +$184K |
|
1814
Universal Corp
UVV
$1.16B
| $4.93M | 0.01% |
74,666
+30,774
| +70% | +$1.7M |
|
1815
PUT
Honeywell
HON
$69.7B
| $4.93M | 0.01% |
+37,859
| New | +$5.04M |
|
|
CIO
1816
DELISTED
City Office REIT
CIO
| $4.91M | 0.01% |
382,605
-325,628
| -46% | -$3.88M |
|
1817
Zscaler
ZS
$27.5B
| $4.9M | 0.01% |
137,137
-59,292
| -30% | -$1.81M |
|
|
ARRS
1818
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $4.9M | 0.01% |
200,478
-392,130
| -66% | -$10.3M |
|
1819
Financial Institutions
FISI
$804M
| $4.88M | 0.01% |
148,298
-103,679
| -41% | -$3.33M |
|
1820
Universal Health Services
UHS
$10.6B
| $4.87M | 0.01% |
43,656
+12,526
| +40% | +$1.47M |
|
1821
CALL
Teva Pharmaceuticals
TEVA
$44B
| $4.86M | 0.01% |
+200,000
| New | +$4.08M |
|
1822
Target Hospitality
TH
$1.7B
| $4.86M | 0.01% |
+500,000
| New | +$4.9M |
|
|
BFYT
1823
CALL
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $4.85M | 0.01% |
+150,000
| New | +$4.57M |
|
1824
Turkcell
TKC
$4.71B
| $4.85M | 0.01% |
741,551
+706,864
| +2,038% | +$5.35M |
|
|
FPRX
1825
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.83M | 0.01% |
305,436
-52,311
| -15% | -$913K |
|
Similar funds
Israel Englander's Q2 2018 Portfolio in Review
As of Q2 2018, Israel Englander held 4,494 positions worth $76.7B, up 2.3% from $74.9B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
Israel Englander's Q2 2018 filing shows 911 new, 1,261 increased, 1,542 reduced and 746 closed positions. Its largest new stake was Evergy: 3,989,462 shares worth $224M. The largest sale was Bank of America, an estimated $296M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2018 buy was Evergy: 3,989,462 shares worth $224M.
- Israel Englander added most to Keurig Dr Pepper in Q2 2018, an estimated $870M increase.
- Israel Englander's biggest Q2 2018 reduction was Bank of America, cutting an estimated $296M.
- Israel Englander fully exited American International in Q2 2018, selling an estimated $170M.
- Israel Englander's ten largest holdings make up 7.3% of its $76.7B portfolio in Q2 2018.
- Israel Englander opened 911 new positions and closed 746 in Q2 2018.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $76.7B.
Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.